{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:32:05Z","timestamp":1790839925876,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"MYOMET"},{"name":"Centre d'Etude des Cellules Souches"},{"name":"AFM-Telethon"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/brain\/awy231","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T19:12:29Z","timestamp":1533669149000},"page":"2855-2865","source":"Crossref","is-referenced-by-count":114,"title":["Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial"],"prefix":"10.1093","volume":"141","author":[{"given":"Guillaume","family":"Bassez","sequence":"first","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence Neuromusculaire Nord-Est-Ile de France, AP-HP, CHU Henri-Mondor Cr\u00e9teil 94010 France"},{"name":"Sorbonne Universit\u00e9 INSERM UMRS 974, AP-HP, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, 75013 Paris France"},{"name":"Institut de Myologie, CHU Piti\u00e9-Salp\u00eatri\u00e8re Paris 75013 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Audureau","sequence":"additional","affiliation":[{"name":"Public Health Department, AP-HP, Henri-Mondor Hospital; DHU A-TVB, IMRB-EA 7376 CEpiA UPEC Cr\u00e9teil 94010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Hogrel","sequence":"additional","affiliation":[{"name":"Institut de Myologie, CHU Piti\u00e9-Salp\u00eatri\u00e8re Paris 75013 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00eblle","family":"Arrouasse","sequence":"additional","affiliation":[{"name":"INSERM CIC1430, AP-HP, CHU Henri-Mondor Cr\u00e9teil 94010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Baghdoyan","sequence":"additional","affiliation":[{"name":"INSERM U861, I-Stem, Corbeil-Essonnes 91100 France"},{"name":"UEVE U861, I-Stem, Corbeil-Essonnes 91100 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Bhugaloo","sequence":"additional","affiliation":[{"name":"INSERM CIC1430, AP-HP, CHU Henri-Mondor Cr\u00e9teil 94010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laurence","family":"Gourlay-Chu","sequence":"additional","affiliation":[{"name":"Institut des Bioth\u00e9rapies, Evry 91000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Le Corvoisier","sequence":"additional","affiliation":[{"name":"INSERM CIC1430, AP-HP, CHU Henri-Mondor Cr\u00e9teil 94010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Peschanski","sequence":"additional","affiliation":[{"name":"INSERM U861, I-Stem, Corbeil-Essonnes 91100 France"},{"name":"UEVE U861, I-Stem, Corbeil-Essonnes 91100 France"},{"name":"CECS, I-Stem, Corbeil-Essonnes 91100 France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"key\n\t\t\t\t20180927040213_awy231-B1","first-page":"111","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180927040213_awy231-B2","first-page":"428","article-title":"Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1","volume":"26","author":"Bachasson","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180927040213_awy231-B3","first-page":"788","article-title":"Gait analysis using accelerometry in dystrophin-deficient dogs","volume":"19","author":"Barthelemy","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180927040213_awy231-B4","first-page":"473","article-title":"Understanding and overcoming metformin gastrointestinal intolerance","volume":"19","author":"Bonnet","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t20180927040213_awy231-B5","first-page":"549","article-title":"Targeting deregulated AMPK\/mTORC1 pathways improves muscle function in myotonic dystrophy type I","volume":"127","author":"Brockhoff","year":"2017","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180927040213_awy231-B6","first-page":"150","article-title":"The 6-min walk distance in healthy subjects: reference standards from seven countries","volume":"37","author":"Casanova","year":"2011","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180927040213_awy231-B7","first-page":"572","article-title":"Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification","volume":"172","author":"De Antonio","year":"2016","journal-title":"Rev Neurol"},{"key":"key\n\t\t\t\t20180927040213_awy231-B8","first-page":"2950","article-title":"The role of AMP-activated protein kinase in the expression of the dystrophin-associated protein complex in skeletal muscle","volume":"32","author":"Dial","year":"2018","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20180927040213_awy231-B9","first-page":"603","article-title":"Report of the second Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-2) international workshop San Sebastian, Spain, October 16, 2013","volume":"25","author":"Gagnon","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180927040213_awy231-B10","first-page":"5188","article-title":"A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1","volume":"22","author":"Gauthier","year":"2013","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20180927040213_awy231-B11","first-page":"e0139944","article-title":"Reconstructing the rasch-built myotonic dystrophy type 1 activity and participation scale","volume":"10","author":"Hermans","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180927040213_awy231-B12","first-page":"719","article-title":"Quantitative myotonia assessment using force relaxation curve modelling","volume":"30","author":"Hogrel","year":"2009","journal-title":"Physiol Meas"},{"key":"key\n\t\t\t\t20180927040213_awy231-B13","first-page":"2184","article-title":"Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib","volume":"29","author":"Jagannathan","year":"2015","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180927040213_awy231-B14","first-page":"1551","article-title":"High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines","volume":"23","author":"Ketley","year":"2014","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20180927040213_awy231-B15","first-page":"695","article-title":"Edstrom L, Widen Holmqvist L, Tollback A. Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study","volume":"43","author":"Kierkegaard","year":"2011","journal-title":"J Rehabil Med"},{"key":"key\n\t\t\t\t20180927040213_awy231-B16","first-page":"943","article-title":"Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy","volume":"17","author":"Kierkegaard","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180927040213_awy231-B17","first-page":"1741","article-title":"AMPK in skeletal muscle function and metabolism","volume":"32","author":"Kjobsted","year":"2018","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20180927040213_awy231-B18","first-page":"1740","article-title":"Myotonic dystrophy: candidate small molecule therapeutics","volume":"22","author":"Konieczny","year":"2017","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20180927040213_awy231-B19","first-page":"e262","article-title":"In Vitro and In Vivo modulation of alternative splicing by the biguanide metformin","volume":"4","author":"Laustriat","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"key\n\t\t\t\t20180927040213_awy231-B20","first-page":"1441","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"74","author":"Logigian","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180927040213_awy231-B21","first-page":"434","article-title":"Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy","volume":"8","author":"Marteyn","year":"2011","journal-title":"Cell Stem Cell"},{"key":"key\n\t\t\t\t20180927040213_awy231-B22","first-page":"336","article-title":"Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy","volume":"56","author":"Mathieu","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180927040213_awy231-B23","first-page":"22","article-title":"Gait disturbances as specific predictive markers of the first fall onset in elderly people: a two-year prospective observational study","volume":"6","author":"Mignardot","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"key\n\t\t\t\t20180927040213_awy231-B24","first-page":"104","article-title":"Ankle dorsi- and plantar-flexion torques measured by dynamometry in healthy subjects from 5 to 80 years","volume":"14","author":"Moraux","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"key\n\t\t\t\t20180927040213_awy231-B25","first-page":"2142","article-title":"Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice","volume":"3","author":"Oana","year":"2013","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180927040213_awy231-B26","first-page":"329","article-title":"Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1","volume":"355","author":"Pandey","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20180927040213_awy231-B27","first-page":"e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180927040213_awy231-B28","first-page":"1103","article-title":"Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial","volume":"34","author":"Puymirat","year":"2012","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20180927040213_awy231-B29","first-page":"2706","article-title":"Studying a drug-like, RNA-focused small molecule library identifies compounds that inhibit RNA toxicity in myotonic dystrophy","volume":"10","author":"Rzuczek","year":"2015","journal-title":"ACS Chem Biol"},{"key":"key\n\t\t\t\t20180927040213_awy231-B30","first-page":"4225","article-title":"Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation","volume":"69","author":"Saito","year":"2009","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180927040213_awy231-B31","first-page":"729","article-title":"Ergogenic properties of metformin in simulated high altitude","volume":"44","author":"Scalzo","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key\n\t\t\t\t20180927040213_awy231-B32","first-page":"5770","article-title":"Biological efficacy and toxicity of diamidines in myotonic dystrophy type 1 models","volume":"58","author":"Siboni","year":"2015","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180927040213_awy231-B33","first-page":"661","article-title":"Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts","volume":"37","author":"Takarada","year":"2015","journal-title":"Brain Dev"},{"key":"key\n\t\t\t\t20180927040213_awy231-B34","first-page":"500","article-title":"Inhibition of the unfolded protein response by metformin in renal proximal tubular epithelial cells","volume":"409","author":"Theriault","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180927040213_awy231-B35","first-page":"18551","article-title":"Pentamidine reverses the splicing defects associated with myotonic dystrophy","volume":"106","author":"Warf","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180927040213_awy231-B36","first-page":"1303","article-title":"The effect of metformin on insulin resistance and exercise parameters in patients with heart failure","volume":"14","author":"Wong","year":"2012","journal-title":"Eur J Heart Fail"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/141\/10\/2855\/25838973\/awy231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T08:02:29Z","timestamp":1538035349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/141\/10\/2855\/5086409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,8,29]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awy231","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,8,29]]}}}